ABCL
Price
$11.37
Change
-$0.87 (-7.11%)
Updated
Oct 22 closing price
Capitalization
3.68B
18 days until earnings call
Intraday BUY SELL Signals
VERU
Price
$2.29
Change
-$0.01 (-0.43%)
Updated
Oct 22 closing price
Capitalization
39.05M
55 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ABCL vs VERU

ABCL vs VERU Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
ABCL vs. VERU commentary
Oct 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABCL is a Hold and VERU is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for ABCL with price predictions
Oct 22, 2026

ABCL in downward trend: price may decline as a result of having broken its higher Bollinger Band on September 29, 2026

ABCL broke above its upper Bollinger Band on September 29, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options. The A.I.dvisor looked at 40 similar instances where the stock broke above the upper band. In 38 of the 40 cases the stock fell afterwards. This puts the odds of success at 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for ABCL moved out of overbought territory on October 01, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 30 similar instances where the indicator moved out of overbought territory. In 26 of the 30 cases, the stock moved lower in the following days. This puts the odds of a move lower at 87%.

The Momentum Indicator moved below the 0 level on October 08, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on ABCL as a result. In 74 of 90 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 82%.

The Moving Average Convergence Divergence Histogram (MACD) for ABCL turned negative on October 06, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 42 similar instances when the indicator turned negative. In 35 of the 42 cases the stock turned lower in the days that followed. This puts the odds of success at 83%.

ABCL moved below its 50-day moving average on October 22, 2026 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ABCL declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 82%.

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 10 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +5.12% 3-day Advance, the price is estimated to grow further. Considering data from situations where ABCL advanced for three days, in 204 of 252 cases, the price rose further within the following month. The odds of a continued upward trend are 81%.

The Aroon Indicator entered an Uptrend today. In 129 of 165 cases where ABCL Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 78%.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 9 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.112) is normal, around the industry mean (2.973). P/E Ratio (-21.056) is within average values for comparable stocks, (-1.705). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (128.121) among similar stocks. P/S Ratio (53.191) is also within normal values, averaging (438.009).

The Tickeron Price Growth Rating for this company is 34 (best 1 - 100 worst), indicating steady price growth. ABCL’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 94 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is 96 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ABCL’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

A.I.Advisor
a Summary for VERU with price predictions
Oct 22, 2026

Momentum Indicator for VERU turns negative, indicating new downward trend

VERU saw its Momentum Indicator move below the 0 level on October 08, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 94 similar instances where the indicator turned negative. In 87 of the 94 cases, the stock moved further down in the following days. The odds of a decline are at 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Moving Average Convergence Divergence Histogram (MACD) for VERU turned negative on October 08, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 40 similar instances when the indicator turned negative. In 40 of the 40 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.

VERU moved below its 50-day moving average on October 06, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for VERU crossed bearishly below the 50-day moving average on October 08, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 15 of 20 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 75%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where VERU declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 89%.

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where VERU's RSI Indicator exited the oversold zone, 25 of 28 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 89%.

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 56 of 69 cases where VERU's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 81%.

The 50-day moving average for VERU moved above the 200-day moving average on September 25, 2026. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Following a +3.48% 3-day Advance, the price is estimated to grow further. Considering data from situations where VERU advanced for three days, in 202 of 244 cases, the price rose further within the following month. The odds of a continued upward trend are 83%.

VERU may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is 71 (best 1 - 100 worst), indicating slightly worse than average price growth. VERU’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 98 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.376) is normal, around the industry mean (2.973). P/E Ratio (-3.948) is within average values for comparable stocks, (-1.705). VERU's Projected Growth (PEG Ratio) (421.660) is very high in comparison to the industry average of (9.059). Dividend Yield (0.122) settles around the average of (128.121) among similar stocks. P/S Ratio (1.966) is also within normal values, averaging (438.009).

The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is 100 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. VERU’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

FUNDAMENTALS RATINGS
ABCL vs VERU: Fundamental Ratings
ABCL
VERU
OUTLOOK RATING
1..100
7159
VALUATION
overvalued / fair valued / undervalued
1..100
9
Undervalued
98
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9498
PRICE GROWTH RATING
1..100
3471
P/E GROWTH RATING
1..100
96100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ABCL's Valuation (9) in the null industry is significantly better than the same rating for VERU (98) in the Household Or Personal Care industry. This means that ABCL’s stock grew significantly faster than VERU’s over the last 12 months.

ABCL's Profit vs Risk Rating (100) in the null industry is in the same range as VERU (100) in the Household Or Personal Care industry. This means that ABCL’s stock grew similarly to VERU’s over the last 12 months.

ABCL's SMR Rating (94) in the null industry is in the same range as VERU (98) in the Household Or Personal Care industry. This means that ABCL’s stock grew similarly to VERU’s over the last 12 months.

ABCL's Price Growth Rating (34) in the null industry is somewhat better than the same rating for VERU (71) in the Household Or Personal Care industry. This means that ABCL’s stock grew somewhat faster than VERU’s over the last 12 months.

ABCL's P/E Growth Rating (96) in the null industry is in the same range as VERU (100) in the Household Or Personal Care industry. This means that ABCL’s stock grew similarly to VERU’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ABCLVERU
RSI
ODDS (%)
Bearish Trend 1 day ago
87%
Bullish Trend 1 day ago
89%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
81%
Momentum
ODDS (%)
Bearish Trend 1 day ago
82%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 1 day ago
90%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 1 day ago
88%
Advances
ODDS (%)
Bullish Trend 11 days ago
81%
Bullish Trend 3 days ago
83%
Declines
ODDS (%)
Bearish Trend 9 days ago
82%
Bearish Trend 1 day ago
89%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
78%
N/A
COMPARISON
Comparison
Oct 23, 2026
Stock price -- (ABCL: $12.24 vs. VERU: $2.30)
Brand notoriety: ABCL and VERU are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABCL: 62% vs. VERU: 47%
Market capitalization -- ABCL: $3.68B vs. VERU: $39.05M
ABCL [@Biotechnology] is valued at $3.68B. VERU’s [@Biotechnology] market capitalization is $39.05M. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $135.64B. The average market capitalization across the [@Biotechnology] industry is $2.18B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABCL’s FA Score shows that 1 FA rating(s) are green while VERU’s FA Score has 0 green FA rating(s).

  • ABCL’s FA Score: 1 green, 4 red.
  • VERU’s FA Score: 0 green, 5 red.
According to our system of comparison, ABCL is a better buy in the long-term than VERU.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABCL’s TA Score shows that 4 TA indicator(s) are bullish while VERU’s TA Score has 5 bullish TA indicator(s).

  • ABCL’s TA Score: 4 bullish, 5 bearish.
  • VERU’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, VERU is a better buy in the short-term than ABCL.

Price Growth

ABCL (@Biotechnology) experienced а -1.05% price change this week, while VERU (@Biotechnology) price change was +7.98% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.10%. For the same industry, the average monthly price growth was -18.18%, and the average quarterly price growth was -15.20%.

Reported Earning Dates

ABCL is expected to report earnings on Nov 09, 2026.

VERU is expected to report earnings on Nov 26, 2026.

Industries' Descriptions

@Biotechnology (-1.10% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
ABCL
Daily Signal:
Gain/Loss:
VERU
Daily Signal:
Gain/Loss:
Interact to see
Advertisement

ABCL and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABCL has been loosely correlated with RXRX. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if ABCL jumps, then RXRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABCL
1D Price
Change %
ABCL100%
-7.11%
RXRX - ABCL
57%
Loosely correlated
-1.65%
CRSP - ABCL
56%
Loosely correlated
-1.01%
ABSI - ABCL
56%
Loosely correlated
-6.67%
VCYT - ABCL
56%
Loosely correlated
-0.39%
AXON - ABCL
51%
Loosely correlated
+2.98%
More

VERU and

Correlation & Price change

A.I.dvisor indicates that over the last year, VERU has been loosely correlated with INDP. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if VERU jumps, then INDP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VERU
1D Price
Change %
VERU100%
-0.43%
INDP - VERU
47%
Loosely correlated
-5.38%
ABCL - VERU
40%
Loosely correlated
-7.11%
RXRX - VERU
39%
Loosely correlated
-1.65%
ABSI - VERU
36%
Loosely correlated
-6.67%
CRSP - VERU
36%
Loosely correlated
-1.01%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ELUT0.860.04
+4.70%
Elutia
TDUP2.330.06
+2.64%
ThredUp
ANF161.491.85
+1.16%
Abercrombie & Fitch Co
QUBT6.59-0.23
-3.37%
Quantum Computing
MRVL223.47-21.29
-8.70%
Marvell Technology